Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Liver cancer, adult primary
Stage/Subtype:  stage A adult primary liver cancer (BCLC)
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Results 1-20 of 20 for your search:
Start Over
Direct Peritoneal Resuscitation Plus Conventional Resuscitation
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 12.0262, NCT01882218
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104-13-302, NCT02112656
Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NRG-GI001, NCI-2014-00849, U10CA180868, NCT02200042
Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RA-2011-025, R01CA161209, NCT01395030
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: UCSF CC# 124511, NCT01687673
Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: NIH WGMCC
Protocol IDs: 130092, 13-CC-0092, NCT01818440
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-259, NCT01840592
Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J1306, NA_00077927, NCT02007954
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: HIPEC, NCT02349958
rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-042, 5R21CA119600, NCT01071941
Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 84
Sponsor: NIH WGMCC
Protocol IDs: 130079, 13-CC-0079, NCT01862718
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 13-148, NCT01938729
Clinical Application of Image Guided Liver Surgery
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201104308, NCT00878215
Microwave Ablation of Resectable Liver Tumors
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-008 Microwave Ablation, NCT00892255
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 229812, NCI-2013-01198, P30CA016056, NCT01896778
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2010-326, NCI-2013-01126, SLI, P30CA013330, NCT01899261
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 16213, NCT01918683
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10036, NCI-2012-00877, NCT02072356
A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 012014-079, NCT02141906
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 14-275, NCT02256982
Start Over